High costs, regulatory challenges, and lack of differentiation in a competitive
marketplace, are raising serious questions on the long-term commercial viability of
sell-side research.
The sell-side investment research industry has been structurally
challenged for the best
part of the last decade. Yet, little has come about in the industry in terms of
innovation or step-change in business process, to address these structural challenges.